| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.27 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |